Taking On The Big Hitters In The Baseball Bat Industry
When it comes to making baseball bats, everyone knows the name Louisville Slugger. When David Chandler started making his own line of bats in 2010, he knew he had a target on his back. Seven years later, the Chandler bat is being used by some of professional baseball's top players.
David Chandler, Founder and President of RxSport Corp., shares how he made a pivot from making high-end furniture to designing baseball bats. He says that he saw a place in the market for a better-crafted product when the MLB was having problems with maple bats breaking. The League was considering outlawing maple as a material for crafting bats, but Chandler says it wasn't a material issue, but a manufacturing issue.
Now Chandler makes bats for MLB all-stars like Aaron Judge and Bryce Harper. He says that the players do a lot of the heavy lifting when it comes to marketing. As more players see how the Chandler Bat performs on the field, the more bats Chandler sells.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
